Can Fite Biopharma Ltd (CANF) ADR Each Representing 300 Ord Shares

Sell:$1.38Buy:$1.47$0.07 (4.79%)

Prices delayed by at least 15 minutes
Sell:$1.38
Buy:$1.47
Change:$0.07 (4.79%)
Deal now
Prices delayed by at least 15 minutes
Sell:$1.38
Buy:$1.47
Change:$0.07 (4.79%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Key people

Ilan Cohen
Chairman of the Board
Pnina Fishman
Chief Executive Officer, Director
Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Sari Fishman
Vice President - Business Development
Yoseph Borenstein
Director
Yaacov Goldman
Independent Director
Guy Regev
Independent Director
Abraham Sartani
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Israel
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US13471N3008
  • Market cap
    $0.00
  • Employees
    5
  • Shares in issue
    3.01bn
  • Exchange
    Tel Aviv Stock Exchange
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.